30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Eidos Therapeutics Inc (EIDX)

Track

Stock chart
Ticker: EIDX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BridgeBio Pharma, Inc.
1 purchase — total 0 USD
Buy 26 Jan 2021
Value US$46,884.37 | Price 52.91 | Shares 22,721
Planned sale 13 Jan 2021
Value US$3,637,048.55 | Price 341.89 | Shares 65,944
Planned sale 13 Jan 2021
Value US$3,650,955.13 | Price 292.96 | Shares 40,608
Planned sale 13 Jan 2021
Value US$615,362.07 | Price 124.72 | Shares 4,934
Planned sale 13 Jan 2021
Value US$184,971.09 | Price 123.48 | Shares 1,498
Planned sale 13 Jan 2021
Value US$69,936.55 | Price 122.27 | Shares 572
Planned sale 13 Jan 2021
Value US$84,292.14 | Price 121.11 | Shares 696
Sale 12 Jan 2021
Value US$219,152.42 | Price 125.45 | Shares 1,747
Sale 11 Jan 2021
Value US$188,407.50 | Price 125.61 | Shares 1,500
Sale 15 Dec 2020
Value US$394,589.19 | Price 112.97 | Shares 3,493
Sale 15 Dec 2020
Value US$1,284,017.98 | Price 112.19 | Shares 11,445
Sale 15 Dec 2020
Value US$845,937.00 | Price 111.31 | Shares 7,600
Sale 15 Dec 2020
Value US$414,251.49 | Price 110.29 | Shares 3,756
Planned sale 2 Dec 2020
Value US$18,593.00 | Price 92.97 | Shares 200
Planned sale 2 Dec 2020
Value US$27,567.00 | Price 91.89 | Shares 300
Planned sale 2 Dec 2020
Value US$63,625.00 | Price 90.63 | Shares 702
Planned sale 2 Dec 2020
Value US$340,402.21 | Price 89.63 | Shares 3,798
Sale 11 Nov 2020
Value US$68,307.57 | Price 75.23 | Shares 908
Sale 11 Nov 2020
Value US$709,859.91 | Price 74.75 | Shares 9,497
Sale 11 Nov 2020
Value US$221,059.82 | Price 73.56 | Shares 3,005
Sale 9 Nov 2020
Value US$121,609.28 | Price 74.93 | Shares 1,623
Planned sale 2 Nov 2020
Value US$15,068.08 | Price 72.10 | Shares 209
Planned sale 2 Nov 2020
Value US$224,676.94 | Price 71.42 | Shares 3,146
Planned sale 2 Nov 2020
Value US$644,208.55 | Price 70.44 | Shares 9,145
Planned sale 29 Oct 2020
Value US$268,625.92 | Price 72.60 | Shares 3,700
Planned sale 29 Oct 2020
Value US$93,473.12 | Price 71.90 | Shares 1,300
Sale 8 Oct 2020
Value US$389,150.87 | Price 74.85 | Shares 5,199
Sale 7 Oct 2020
Value US$408,748.04 | Price 75.08 | Shares 5,444
Planned sale 1 Oct 2020
Value US$252,923.14 | Price 52.35 | Shares 4,831
Planned sale 30 Sep 2020
Value US$5,200.00 | Price 52.00 | Shares 100
Planned sale 30 Sep 2020
Value US$3,593.52 | Price 52.08 | Shares 69
Planned sale 17 Sep 2020
Value US$289,258.88 | Price 50.16 | Shares 5,767
Planned sale 16 Sep 2020
Value US$156,609.51 | Price 50.16 | Shares 3,122
Planned sale 15 Sep 2020
Value US$50,064.00 | Price 50.06 | Shares 1,000
Planned sale 14 Sep 2020
Value US$5,550.00 | Price 50.00 | Shares 111
Planned sale 10 Sep 2020
Value US$117,500.00 | Price 47.00 | Shares 2,500
Planned sale 3 Aug 2020
Value US$20,446.35 | Price 40.89 | Shares 500
Planned sale 3 Aug 2020
Value US$269,671.65 | Price 40.25 | Shares 6,700
Planned sale 3 Aug 2020
Value US$109,331.88 | Price 39.05 | Shares 2,800
Planned sale 7 Jul 2020
Value US$250,000.00 | Price 50.00 | Shares 5,000
Planned sale 3 Jun 2020
Value US$250,000.00 | Price 50.00 | Shares 5,000
Planned sale 28 May 2020
Value US$250,000.00 | Price 50.00 | Shares 5,000
Planned sale 26 May 2020
Value US$117,500.00 | Price 47.00 | Shares 2,500
Planned sale 1 May 2020
Value US$865.20 | Price 43.26 | Shares 20
Planned sale 1 May 2020
Value US$50,220.45 | Price 42.56 | Shares 1,180
Planned sale 1 May 2020
Value US$43,286.56 | Price 41.23 | Shares 1,050
Planned sale 1 May 2020
Value US$314,061.00 | Price 40.52 | Shares 7,750
Planned sale 24 Apr 2020
Value US$107,650.00 | Price 50.00 | Shares 2,153
Planned sale 23 Apr 2020
Value US$142,350.00 | Price 50.00 | Shares 2,847
Sale 20 Apr 2020
Value US$99,580.00 | Price 49.79 | Shares 2,000
Sale 26 Mar 2020
Value US$97,700.00 | Price 48.85 | Shares 2,000
Sale 26 Mar 2020
Value US$143,610.00 | Price 47.87 | Shares 3,000
Sale 2 Mar 2020
Value US$53,060.00 | Price 53.06 | Shares 1,000
Sale 2 Mar 2020
Value US$103,920.00 | Price 51.96 | Shares 2,000
Sale 2 Mar 2020
Value US$515,706.00 | Price 51.57 | Shares 10,000
Sale 13 Feb 2020
Value US$540,000.00 | Price 54.00 | Shares 10,000
Planned sale 3 Feb 2020
Value US$388,636.12 | Price 53.89 | Shares 7,211
Planned sale 3 Feb 2020
Value US$282,003.66 | Price 53.32 | Shares 5,289
Sale 15 Jan 2020
Value US$196,900.00 | Price 55.00 | Shares 3,580
Sale 14 Jan 2020
Value US$353,171.90 | Price 55.01 | Shares 6,420
Sale 18 Dec 2019
Value US$107,760.60 | Price 63.31 | Shares 1,702
Sale 18 Dec 2019
Value US$51,552.52 | Price 62.49 | Shares 825
Sale 18 Dec 2019
Value US$614,480.41 | Price 61.61 | Shares 9,973
Sale 9 Dec 2019
Value US$54,101.09 | Price 60.05 | Shares 901
Sale 9 Dec 2019
Value US$542,468.73 | Price 59.62 | Shares 9,099
Sale 6 Dec 2019
Value US$528,921.66 | Price 59.43 | Shares 8,900
Sale 6 Dec 2019
Value US$40,793.97 | Price 58.28 | Shares 700
Sale 6 Dec 2019
Value US$22,736.00 | Price 56.84 | Shares 400
Sale 4 Dec 2019
Value US$589,048.00 | Price 58.90 | Shares 10,000
Sale 4 Dec 2019
Value US$71,271.84 | Price 59.39 | Shares 1,200
Sale 4 Dec 2019
Value US$515,671.20 | Price 58.60 | Shares 8,800
Sale 3 Dec 2019
Value US$238,582.80 | Price 59.65 | Shares 4,000
Sale 3 Dec 2019
Value US$318,332.16 | Price 58.95 | Shares 5,400
Sale 3 Dec 2019
Value US$34,692.72 | Price 57.82 | Shares 600
Sale 25 Nov 2019
Value US$565,218.00 | Price 56.52 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-01-26 2021-01-26 B Purchase
BridgeBio Pharma, Inc.
Large shareholder
22,721
52.91
US$46,884 		22,721 52.91 US$46,884
2021-01-15 2021-01-13 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
65,944 -47.4%
341.89
US$3,637,049 		65,944 -47.4% 341.89 US$3,637,049
2021-01-15 2021-01-13 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
40,608 -29.6%
292.96
US$3,650,955 		40,608 -29.6% 292.96 US$3,650,955
2021-01-15 2021-01-13 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
4,934 -1.6%
124.72
US$615,362 		4,934 -1.6% 124.72 US$615,362
2021-01-15 2021-01-13 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
1,498 -0.5%
123.48
US$184,971 		1,498 -0.5% 123.48 US$184,971
2021-01-15 2021-01-13 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
572 -0.2%
122.27
US$69,937 		572 -0.2% 122.27 US$69,937
2021-01-15 2021-01-13 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
696 -0.2%
121.11
US$84,292 		696 -0.2% 121.11 US$84,292
2021-01-13 2021-01-12 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
1,747 -100.0%
125.45
US$219,152 		1,747 -100.0% 125.45 US$219,152
2021-01-13 2021-01-11 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
1,500 -100.0%
125.61
US$188,408 		1,500 -100.0% 125.61 US$188,408
2020-12-16 2020-12-15 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
3,493 -6.5%
112.97
US$394,589 		3,493 -6.5% 112.97 US$394,589
2020-12-16 2020-12-15 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
11,445 -17.5%
112.19
US$1,284,018 		11,445 -17.5% 112.19 US$1,284,018
2020-12-16 2020-12-15 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
7,600 -10.4%
111.31
US$845,937 		7,600 -10.4% 111.31 US$845,937
2020-12-16 2020-12-15 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
3,756 -4.9%
110.29
US$414,251 		3,756 -4.9% 110.29 US$414,251
2020-12-04 2020-12-02 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
200 -0.1%
92.97
US$18,593 		200 -0.1% 92.97 US$18,593
2020-12-04 2020-12-02 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
300 -0.1%
91.89
US$27,567 		300 -0.1% 91.89 US$27,567
2020-12-04 2020-12-02 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
702 -0.2%
90.63
US$63,625 		702 -0.2% 90.63 US$63,625
2020-12-04 2020-12-02 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
3,798 -1.2%
89.63
US$340,402 		3,798 -1.2% 89.63 US$340,402
2020-11-13 2020-11-11 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
908 -1.7%
75.23
US$68,308 		908 -1.7% 75.23 US$68,308
2020-11-13 2020-11-11 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
9,497 -15.2%
74.75
US$709,860 		9,497 -15.2% 74.75 US$709,860
2020-11-13 2020-11-11 S Sale
1.5
Turtle Cameron

Chief Business Officer

Officer
3,005 -4.6%
73.56
US$221,060 		3,005 -4.6% 73.56 US$221,060
2020-11-10 2020-11-09 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
1,623 -100.0%
74.93
US$121,609 		1,623 -100.0% 74.93 US$121,609
2020-11-03 2020-11-02 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
209 -0.3%
72.10
US$15,068 		209 -0.3% 72.10 US$15,068
2020-11-03 2020-11-02 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
3,146 -4.6%
71.42
US$224,677 		3,146 -4.6% 71.42 US$224,677
2020-11-03 2020-11-02 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
9,145 -11.7%
70.44
US$644,209 		9,145 -11.7% 70.44 US$644,209
2020-10-30 2020-10-29 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
3,700 -1.1%
72.60
US$268,626 		3,700 -1.1% 72.60 US$268,626
2020-10-30 2020-10-29 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
1,300 -0.4%
71.90
US$93,473 		1,300 -0.4% 71.90 US$93,473
2020-10-09 2020-10-08 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
5,199 -100.0%
74.85
US$389,151 		5,199 -100.0% 74.85 US$389,151
2020-10-09 2020-10-07 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
5,444 -100.0%
75.08
US$408,748 		5,444 -100.0% 75.08 US$408,748
2020-10-02 2020-10-01 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
4,831 -1.5%
52.35
US$252,923 		4,831 -1.5% 52.35 US$252,923
2020-10-02 2020-09-30 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
100 -0.0%
52.00
US$5,200 		100 -0.0% 52.00 US$5,200
2020-10-02 2020-09-30 PlS Planned sale
Sinha Uma

Chief Scientific Officer

Executive Director
69 -0.0%
52.08
US$3,594 		69 -0.0% 52.08 US$3,594
2020-09-18 2020-09-17 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
5,767 -1.5%
50.16
US$289,259 		5,767 -1.5% 50.16 US$289,259
2020-09-16 2020-09-16 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
3,122 -0.8%
50.16
US$156,610 		3,122 -0.8% 50.16 US$156,610
2020-09-16 2020-09-15 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
1,000 -0.3%
50.06
US$50,064 		1,000 -0.3% 50.06 US$50,064
2020-09-16 2020-09-14 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
111 -0.0%
50.00
US$5,550 		111 -0.0% 50.00 US$5,550
2020-09-11 2020-09-10 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
2,500 -3.4%
47.00
US$117,500 		2,500 -3.4% 47.00 US$117,500
2020-08-05 2020-08-03 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
500 -0.7%
40.89
US$20,446 		500 -0.7% 40.89 US$20,446
2020-08-05 2020-08-03 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
6,700 -8.6%
40.25
US$269,672 		6,700 -8.6% 40.25 US$269,672
2020-08-05 2020-08-03 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
2,800 -3.5%
39.05
US$109,332 		2,800 -3.5% 39.05 US$109,332
2020-07-09 2020-07-07 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
5,000 -1.3%
50.00
US$250,000 		5,000 -1.3% 50.00 US$250,000
2020-06-05 2020-06-03 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
5,000 -1.3%
50.00
US$250,000 		5,000 -1.3% 50.00 US$250,000
2020-06-01 2020-05-28 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
5,000 -1.2%
50.00
US$250,000 		5,000 -1.2% 50.00 US$250,000
2020-05-28 2020-05-26 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
2,500 -3.2%
47.00
US$117,500 		2,500 -3.2% 47.00 US$117,500
2020-05-05 2020-05-01 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
20 -0.0%
43.26
US$865 		20 -0.0% 43.26 US$865
2020-05-05 2020-05-01 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
1,180 -1.5%
42.56
US$50,220 		1,180 -1.5% 42.56 US$50,220
2020-05-05 2020-05-01 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
1,050 -1.4%
41.23
US$43,287 		1,050 -1.4% 41.23 US$43,287
2020-05-05 2020-05-01 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer

Officer
7,750 -9.1%
40.52
US$314,061 		7,750 -9.1% 40.52 US$314,061
2020-04-27 2020-04-24 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
2,153 -0.5%
50.00
US$107,650 		2,153 -0.5% 50.00 US$107,650
2020-04-27 2020-04-23 PlS Planned sale
3.9
Fox Jonathan C

See Remarks

Officer
2,847 -0.7%
50.00
US$142,350 		2,847 -0.7% 50.00 US$142,350
2020-04-22 2020-04-20 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
2,000 -100.0%
49.79
US$99,580 		2,000 -100.0% 49.79 US$99,580
2020-03-30 2020-03-26 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
2,000 -100.0%
48.85
US$97,700 		2,000 -100.0% 48.85 US$97,700
2020-03-30 2020-03-26 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
3,000 -60.0%
47.87
US$143,610 		3,000 -60.0% 47.87 US$143,610
2020-03-04 2020-03-02 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
1,000 -100.0%
53.06
US$53,060 		1,000 -100.0% 53.06 US$53,060
2020-03-04 2020-03-02 S Sale
2.6
Valle Franco

Senior Vice President, Finance

Officer
2,000 -66.7%
51.96
US$103,920 		2,000 -66.7% 51.96 US$103,920
2020-03-04 2020-03-02 S Sale
3.9
Fox Jonathan C

See Remarks

Officer
10,000 -2.4%
51.57
US$515,706 		10,000 -2.4% 51.57 US$515,706
2020-02-19 2020-02-13 S Sale
3.9
Fox Jonathan C

See Remarks

Officer
10,000 -2.3%
54.00
US$540,000 		10,000 -2.3% 54.00 US$540,000
2020-02-05 2020-02-03 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer
7,211 -8.3%
53.89
US$388,636 		7,211 -8.3% 53.89 US$388,636
2020-02-05 2020-02-03 PlS Planned sale
1.5
Turtle Cameron

Chief Business Officer
5,289 -5.7%
53.32
US$282,004 		5,289 -5.7% 53.32 US$282,004
2020-01-16 2020-01-15 S Sale
3.9
Fox Jonathan C

See Remarks
3,580 -0.8%
55.00
US$196,900 		3,580 -0.8% 55.00 US$196,900
2020-01-16 2020-01-14 S Sale
3.9
Fox Jonathan C

See Remarks
6,420 -1.5%
55.01
US$353,172 		6,420 -1.5% 55.01 US$353,172
2019-12-20 2019-12-18 S Sale Sinha Uma

Chief Scientific Officer

Executive Director
1,702 -0.5%
63.31
US$107,761 		1,702 -0.5% 63.31 US$107,761
2019-12-20 2019-12-18 S Sale Sinha Uma

Chief Scientific Officer

Executive Director
825 -0.2%
62.49
US$51,553 		825 -0.2% 62.49 US$51,553
2019-12-20 2019-12-18 S Sale Sinha Uma

Chief Scientific Officer

Executive Director
9,973 -2.9%
61.61
US$614,480 		9,973 -2.9% 61.61 US$614,480
2019-12-11 2019-12-09 S Sale Siu Christine

CFO and Secretary

Officer
901 -2.4%
60.05
US$54,101 		901 -2.4% 60.05 US$54,101
2019-12-11 2019-12-09 S Sale Siu Christine

CFO and Secretary

Officer
9,099 -19.6%
59.62
US$542,469 		9,099 -19.6% 59.62 US$542,469
2019-12-10 2019-12-06 S Sale Turtle Cameron

Chief Business Officer

Officer
8,900 -9.5%
59.43
US$528,922 		8,900 -9.5% 59.43 US$528,922
2019-12-10 2019-12-06 S Sale Turtle Cameron

Chief Business Officer

Officer
700 -0.7%
58.28
US$40,794 		700 -0.7% 58.28 US$40,794
2019-12-10 2019-12-06 S Sale Turtle Cameron

Chief Business Officer

Officer
400 -0.4%
56.84
US$22,736 		400 -0.4% 56.84 US$22,736
2019-12-05 2019-12-04 S Sale Fox Jonathan C

See Remarks

Officer
10,000 -2.2%
58.90
US$589,048 		10,000 -2.2% 58.90 US$589,048
2019-12-05 2019-12-04 S Sale Siu Christine

CFO and Secretary

Officer
1,200 -3.2%
59.39
US$71,272 		1,200 -3.2% 59.39 US$71,272
2019-12-05 2019-12-04 S Sale Siu Christine

CFO and Secretary

Officer
8,800 -18.9%
58.60
US$515,671 		8,800 -18.9% 58.60 US$515,671
2019-12-05 2019-12-03 S Sale Siu Christine

CFO and Secretary

Officer
4,000 -9.9%
59.65
US$238,583 		4,000 -9.9% 59.65 US$238,583
2019-12-05 2019-12-03 S Sale Siu Christine

CFO and Secretary

Officer
5,400 -11.8%
58.95
US$318,332 		5,400 -11.8% 58.95 US$318,332
2019-12-05 2019-12-03 S Sale Siu Christine

CFO and Secretary

Officer
600 -1.3%
57.82
US$34,693 		600 -1.3% 57.82 US$34,693
2019-11-27 2019-11-25 S Sale
3.9
Fox Jonathan C

See Remarks
10,000 -2.2%
56.52
US$565,218 		10,000 -2.2% 56.52 US$565,218
Explore more

More insider trading research around Eidos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America